Literature DB >> 427736

Symptomatology as an indicator of recurrent or metastatic breast cancer.

D P Winchester, S F Sener, J D Khandekar, M A Oviedo, M P Cunningham, J A Caprini, F E Burkett, E F Scanlon.   

Abstract

Eighty-seven patients with recurrent breast cancer after mastectomy were analyzed for patterns of recurrence and methods of detection. After an average disease-free interval of 30 months, 38% developed osseous metastases, 16% recurred locally, 10% had local plus systemic disease, 10% showed pulmonary metastases and the remainder were distributed among liver, brain, and remaining breast disease. In 79 patients recurrence was heralded by symptoms. Physical examination in five asymptomatic patients revealed local or supraclavicular recurrence. In only three asymptomatic patients was recurrence documented by "routine" chest x-rays (in two), or liver enzymes/liver scan (in one). No asymptomatic disease was found by bone scan. It is concluded that periodic history, physical examination, and chest x-rays are the most important components in the follow-up of breast cancer patients. Radioisotope scans and other radiographs are valuable in confirming symptomatic disease and detecting additional diseases, but cannot be recommended routinely in the asymptomatic patient because of low yield and cost.

Entities:  

Mesh:

Year:  1979        PMID: 427736     DOI: 10.1002/1097-0142(197903)43:3<956::aid-cncr2820430326>3.0.co;2-l

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  18 in total

1.  Costs and benefits of routine follow-up after curative treatment for endometrial cancer.

Authors:  O O Agboola; E Grunfeld; D Coyle; G A Perry
Journal:  CMAJ       Date:  1997-10-01       Impact factor: 8.262

2.  Quality of post-treatment surveillance of early stage breast cancer in Texas.

Authors:  Abhishek D Parmar; Kristin M Sheffield; Gabriela M Vargas; Yimei Han; Celia Chao; Taylor S Riall
Journal:  Surgery       Date:  2013-08       Impact factor: 3.982

3.  Routine follow up of breast cancer in primary care: randomised trial.

Authors:  E Grunfeld; D Mant; P Yudkin; R Adewuyi-Dalton; D Cole; J Stewart; R Fitzpatrick; M Vessey
Journal:  BMJ       Date:  1996-09-14

Review 4.  [Indications for nuclear medicine diagnosis in trauma surgery].

Authors:  S Högerle; E Nitzsche; F Bonnaire; A Otte; E H Kuner; E Moser
Journal:  Unfallchirurgie       Date:  1997-12

5.  Usefulness of surveillance imaging in patients with head and neck cancer who are treated with definitive radiotherapy.

Authors:  Sweet Ping Ng; Courtney Pollard; Joel Berends; Zeina Ayoub; Mona Kamal; Adam S Garden; Houda Bahig; Scott B Cantor; Andrew J Schaefer; Temitayo Ajayi; G Brandon Gunn; Steven J Frank; Heath Skinner; Jack Phan; William H Morrison; Renata Ferrarotto; Jason M Johnson; Abdallah S R Mohamed; Stephen Y Lai; Amy C Hessel; Erich M Sturgis; Randal S Weber; Clifton D Fuller; David I Rosenthal
Journal:  Cancer       Date:  2019-02-12       Impact factor: 6.860

Review 6.  Systemic therapy in breast cancer: efficacy and cost utility.

Authors:  J F Corry; P E Lønning
Journal:  Pharmacoeconomics       Date:  1994-03       Impact factor: 4.981

7.  Clinical surveillance for early stage breast cancer: an analysis of claims data.

Authors:  M S Simon; M Stano; R K Severson; M S Hoff; D W Smith
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

8.  Value of bone scanning in the follow-up of breast cancer patients. A study of 1000 cases.

Authors:  H Schünemann; P J Langecker; W Ellgas; A Leonhardt; H Merkl
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

9.  Adjuvant CMF effect on site of first recurrence, and appropriate follow-up intervals, in operable breast cancer with positive axillary nodes.

Authors:  P Valagussa; J D Tess; A Rossi; G Tancini; A Banfi; G Bonadonna
Journal:  Breast Cancer Res Treat       Date:  1981       Impact factor: 4.872

10.  Evaluation of follow-up methods to detect relapse after mastectomy in breast cancer patients.

Authors:  B Cantwell; J J Fennelly; M Jones
Journal:  Ir J Med Sci       Date:  1982-01       Impact factor: 1.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.